BRAF and differentiated thyroid carcinoma: They reported that BRAF mutations were associated with histologic subtypes, the presence of distant metastases in papillary thyroid carcinoma, and a higher clinical stage, even though the same results were initially published in a meta-analysis by Tufano et al.